Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Shi X, Zhang Y, Zheng J, Pan J
J Med Chem 2022;65:8208-26.PubMedPMC 119
Their concerns were categorized as follows: Overprescribing (clinically inappropriate prescribing): 56% Compromised continuity of care (e.g., follow-up visits, titration, tapering off medication): 50% Lack of complete medical history: 47% Medication interactions and/or side effect management: 43% Lack of transparency to the patients broader care team: 32% Prevalence of compounded GLP-1s/GIPs: 32% Lack of holistic support of weight management: 24% Researchers have raised marketing and safety concerns about compounded and counterfeit GLP-1s, and the FDA recommends that patients "obtain a prescription from their doctor and fill the prescription at a state-licensed pharmacy." However, patient demand for these drugs is likely to persist due to their significantly lower costs
Correctly selecting GLP-1 injection sites is crucial for effective therapy and to minimize discomfort
Discover related topics, compare insights, and keep learning
This is especially true if you are new to the medication, experiencing unusual symptoms, or have any underlying health conditions that might require specific guidance
.webp)
